These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28746718)

  • 1. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.
    Vernali S; Waxweiler WT; Dillon PM; Kanetsky PA; Orlow I; Luo L; Busam KJ; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    JAMA Dermatol; 2017 Oct; 153(10):1026-1031. PubMed ID: 28746718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
    Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
    JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients.
    Rayner JE; McMeniman EK; Duffy DL; De'Ambrosis B; Smithers BM; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1076-1083. PubMed ID: 30680790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
    Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
    Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited variation at MC1R and histological characteristics of primary melanoma.
    Taylor NJ; Busam KJ; From L; Groben PA; Anton-Culver H; Cust AE; Begg CB; Dwyer T; Gallagher RP; Gruber SB; Orlow I; Rosso S; Thomas NE; Zanetti R; Rebbeck TR; Berwick M; Kanetsky PA
    PLoS One; 2015; 10(3):e0119920. PubMed ID: 25790105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
    Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
    Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors of Subsequent Primary Melanomas in Austria.
    Müller C; Wendt J; Rauscher S; Sunder-Plassmann R; Richtig E; Fae I; Fischer G; Okamoto I
    JAMA Dermatol; 2019 Feb; 155(2):188-195. PubMed ID: 30566178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelanotic melanoma.
    Gong HZ; Zheng HY; Li J
    Melanoma Res; 2019 Jun; 29(3):221-230. PubMed ID: 30672881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
    Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
    Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.
    Fargnoli MC; Sera F; Suppa M; Piccolo D; Landi MT; Chiarugi A; Pellegrini C; Seidenari S; Peris K
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1768-75. PubMed ID: 24588892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study.
    Cust AE; Goumas C; Vuong K; Davies JR; Barrett JH; Holland EA; Schmid H; Agha-Hamilton C; Armstrong BK; Kefford RF; Aitken JF; Giles GG; Bishop D; Newton-Bishop JA; Hopper JL; Mann GJ; Jenkins MA
    BMC Cancer; 2013 Sep; 13():406. PubMed ID: 24134749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
    Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
    J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms].
    Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
    Actas Dermosifiliogr; 2012; 103(1):44-50. PubMed ID: 21737053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.
    Pasquali E; García-Borrón JC; Fargnoli MC; Gandini S; Maisonneuve P; Bagnardi V; Specchia C; Liu F; Kayser M; Nijsten T; Nagore E; Kumar R; Hansson J; Kanetsky PA; Ghiorzo P; Debniak T; Branicki W; Gruis NA; Han J; Dwyer T; Blizzard L; Landi MT; Palmieri G; Ribas G; Stratigos A; Council ML; Autier P; Little J; Newton-Bishop J; Sera F; Raimondi S;
    Int J Cancer; 2015 Feb; 136(3):618-31. PubMed ID: 24917043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermoscopy, reflectance confocal microscopy and histopathology of an amelanotic melanoma from an individual heterozygous for MC1R and tyrosinase variant alleles.
    Curchin C; Wurm E; Jagirdar K; Sturm R; Soyer P
    Australas J Dermatol; 2012 Nov; 53(4):291-4. PubMed ID: 22497519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
    Kanetsky PA; Panossian S; Elder DE; Guerry D; Ming ME; Schuchter L; Rebbeck TR
    Cancer; 2010 May; 116(10):2416-28. PubMed ID: 20301115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
    Strazzulla LC; Li X; Zhu K; Okhovat JP; Lee SJ; Kim CC
    J Am Acad Dermatol; 2019 May; 80(5):1292-1298. PubMed ID: 30654075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MC1R variants increase risk of melanomas harboring BRAF mutations.
    Fargnoli MC; Pike K; Pfeiffer RM; Tsang S; Rozenblum E; Munroe DJ; Golubeva Y; Calista D; Seidenari S; Massi D; Carli P; Bauer J; Elder DE; Bastian BC; Peris K; Landi MT
    J Invest Dermatol; 2008 Oct; 128(10):2485-90. PubMed ID: 18368129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocortin 1 receptor variants and their association with phenotypic characteristics and sporadic multiple primary melanomas in a cohort of 402 Spanish subjects.
    Vírseda-González D; Lázaro-Ochaita P; Ribas Despuig G; Avilés-Izquierdo JA
    Exp Dermatol; 2023 May; 32(5):678-683. PubMed ID: 36602233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.